The Clear Alternative

thinking beyond the traditional

Gain Clarity Now

We Feel Your Pain

strategies of the past struggle to deliver results

You Seek A Solution

through education clarity takes hold and the answers come

About 361 Capital

361 Capital is a firm with a long history of managing alternative investment portfolios. For almost two decades the principals of the firm have been creating portfolios using alternative investments for major institutions, financial intermediaries, and wealthy individuals. We have a unique view resulting from our breadth of experience creating hedge fund of funds using some of the industry’s premier managers, and managing our own hedge funds.

+ Learn More

Education Center

Visit our Alternatives Education Center (AEC) to view educational videos powered by Morningstar, weekly research insights and white papers written by our investment team, and proprietary portfolio tools designed to support the use of alternative investments.

 + Learn More

 

Products

361 Managed Futures Strategy Fund

The 361 Managed Futures Strategy Fund is a tactically managed futures strategy that seeks positive absolute returns that have a low correlation to the broader stock and bond market averages. 

+ Learn More

361 Absolute Alpha Fund

A market neutral equity fund designed with the intent to provide capital appreciation, low volatility, and low correlation relative to the broad domestic and foreign equity markets. 

+ Learn More

 

361 Long/Short Equity Fund

The 361 Long/Short Equity Fund is an actively managed long/short equity fund that attempts to replicate the returns of long/short equity strategies using ETFs. 

+ Learn More

361 Multi-Strategy ETF Portfolio

The 361 Multi-Strategy ETF Portfolio attempts to replicate the returns of our top-quartile performing Institutional Strategy Fund portfolio.

+ Learn More

361 Long/Short Equity ETF Portfolio

The 361 Long/Short Equity ETF Portfolio attempts to replicate the returns of top-quartile performing long/short equity hedge fund managers identified using our proprietary quantitative and screening methodologies.

+ Learn More